A Study of MET233 in Combination With MET097 in Individuals With Obesity or Overweight With or Without Diabetes

Summary

This study is designed to test how well the combination of MET233 with MET097 works to treat individuals with obesity or overweight with or without diabetes.

Timeline

Start

2025-03-06

Primary completion

2026-09-15

Completion

2026-09-15

Publications

• Bailey CJ, Flatt PR, Conlon JM. Long-acting amylin-related peptides as therapies for obesity and type 2 diabetes. Peptides. 2026 Mar;196:171480. doi: 10.1016/j.peptides.2026.171480. Epub 2026 Feb 24.

Drugs

Indications